Kailera Therapeutics, Inc. Common Stock (KLRA) — Defensive Interval Ratio
Kailera Therapeutics, Inc. Common Stock (KLRA) has a Defensive Interval Ratio of 3034 days as of December 2025. Defensive assets of $385.79 Million (cash $-, short-term investments $385.79 Million, receivables $-) cover 3034 days of daily cash needs of $127.14K/day. See Kailera Therapeutics, Inc. Common Stock short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Kailera Therapeutics, Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how Kailera Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 3034 days, meaning defensive assets of $385.79 Million can fund 3034 days of operations without new revenue. Also explore Kailera Therapeutics, Inc. Common Stock (KLRA) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Kailera Therapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Kailera Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Kailera Therapeutics, Inc. Common Stock.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 3034 days | $385.79 Million | $127.14K/day | $- | $385.79 Million | ▲ +3034 days |
| 2024 | 0 days | $0.00 | $18.93K/day | $- | $0.00 | — |